ADAR1 Capital Management, LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1940272
AUSTIN, TX
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,330,000
+$330,400 QoQ
Shares Held
133,000
+26.7% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#111
of 316 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $25,810,127 across 10 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
277,848 | $9,413,490 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
494,378 | $8,879,028 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
26,913 | $1,721,086 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
133,000 | $1,330,000 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
27,842 | $1,294,931 | |
| 6 | INM |
InMed Pharmaceuticals Inc.
|
800,000 | $1,240,000 | |
| 7 | TXMD |
TherapeuticsMD, Inc.
|
342,447 | $756,807 | |
| 8 | EOLS |
Evolus, Inc.
|
100,000 | $694,000 |
All Filings in BCRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,330,000 | 133,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $999,600 | 105,000 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $351,000 | 45,000 | Shares | Sole | 2026-02-18 | |
| 2025-03-31 | $75,000 | 10,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $263,200 | 35,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $266,000 | 35,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $181,692 | 29,400 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||